Skip to main content
Fig. 4 | BMC Psychiatry

Fig. 4

From: Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study

Fig. 4

Change in Brief Psychiatric Rating Scale (BPRS) – Total Score over Time in Substance Users and Non-Users. A Patients reporting any substance use at baseline. B Patients reporting alcohol use at baseline. C Patients reporting cannabis use at baseline

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us